Delivery Order SPE2DB20D3303-SPE2DB25FA2AQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 tablets per package. This is a firm fixed-price delivery order with a ceiling value of $1,315.41, with an ultimate completion date of July 23, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.65 to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitive award, which utilized no set-aside designation, was executed under a firm fixed-price contract structure with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The dapagliflozin delivery supports the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 with a ceiling value of $8,612.00. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025. The contract was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $5,346.26 delivery order to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, indicating it is issued under a larger indefinite delivery contract (IDC) vehicle. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a $9,849.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30 units. This competitively awarded contract, with an ultimate completion date of July 29, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a single delivery order under a larger contract vehicle. This...
- The Defense Logistics Agency awarded a $1,983.31 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30. This non-set-aside contract is classified as a child award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 with a ceiling value of $10,996.65. This is a firm fixed price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.68 firm fixed-price contract is for the delivery of dapagliflozin 10 mg tablets. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,857.35 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of dapagliflozin 10 mg tablets in quantities of 30 units. The contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX). Performance will be completed by July 25, 2025, with fulfillment occurring at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package at a ceiling value of $1,333.77. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2AQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,399.80 and an ultimate completion date of August 1, 2025. The contract utilizes no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The dapagliflozin supply fulfills federal medical procurement needs for military and veteran healthcare systems, consistent with the company's extensive portfolio of diabetes medications and other therapeutic pharmaceuticals delivered through the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/31/25 |